Clinical utility of the imunohistochemical co-expression of p53 and MDM2 in thyroid follicular lesions
2021
Abstract In order to investigate the possible correlation between p53 and MDM2 co-expression with clinicopathological features of differentiated thyroid cancer (DTC) and its use as diagnostic and/or prognostic markers, we used immunohistochemistry to evaluate 317 thyroid samples including 208 DTC and 94 benign nodules, in addition to 15 normal tissues. MDM2 and p53 expression were highly associated (r = 0.7161; p
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
41
References
0
Citations
NaN
KQI